This site is intended for Healthcare Professionals only

remdesivir

remdesivir covid-19.jpg

Once-promising Covid drug has 'little to no survival impact'

Remdesivir – hailed in May as a potential breakthrough – has little impact on survival rates for patients hospitalised with the virus, says WHO.

19 Oct 2020 , 1 Min Article

remdesivir covid-19.jpg

Remdesivir gets EU approval as Trump hoovers up supplies

The European Commission granted a conditional marketing authorisation for the drug earlier today

03 Jul 2020 , 1 Min Article

remdesivir covid-19.jpg

Unlicensed anti-viral gets MHRA approval for Covid-19

The MHRA has said it supports the use of the unlicensed anti-viral remdesivir in some Covid-19 patients with “high unmet medical need”.

26 May 2020 , 1 Min Article

Change privacy settings